HLA-A3 increases and HLA-DR1 decreases the risk of acute graft-versus-host disease after HLA-matched sibling bone marrow transplantation for chronic myelogenous leukaemia.

作者: Richard E. Clark , Jo Hermans , Alejandro Madrigal , David Nachbaur , Gabriele Kropshofer

DOI: 10.1046/J.1365-2141.2001.02897.X

关键词: HistocompatibilityImmunologyHLA-DR1Risk factorImmunopathologyHistocompatibility TestingHuman leukocyte antigenLower riskMedicineBone marrow

摘要: Frequencies of human leucocyte antigens (HLA)-A, -B and -DR were determined in 751 patients with chronic myelogenous leukaemia (CML) reported to the European Group for Blood Marrow Transplantation after bone marrow transplantation from HLA-identical family donors related occurrence graft-versus-host disease (GVHD). HLA-A3 DR1 significantly associated acute GVHD, first a higher risk (44% HLA-A3(+) versus 34% HLA-A3(-) patients) latter lower (28% HLA-DR1(+) 38% HLA-DR1(-) developing GVHD grade II--IV. Both factors independent known variables as shown multivariate analysis. The results show that MHC alleles independently influence incidence an donor chronic-phase CML. Possible mechanisms might include HLA antigen-specific allele-associated effect, and/or non-specific immune hypo- or hyper-responsiveness.

参考文章(35)
E. Donnall Thomas, Rainer Storb, Reginald A. Clift, Alexander Fefer, F. Leonard Johnson, Paul E. Neiman, Kenneth G. Lerner, Harold Glucksberg, C. Dean Buckner, Bone-Marrow Transplantation New England Journal of Medicine. ,vol. 292, pp. 832- 843 ,(1975) , 10.1056/NEJM197504172921605
John A. Hansen, James M. Woodruff, Robert A. Good, The Graft-vs.-Host Reaction in Man Immunodermatology. pp. 229- 257 ,(1981) , 10.1007/978-1-4615-7228-2_15
D. Niederwieser, J.H.F. Falkenburg, J.H. v Biezen, M. Oudshoorn, R. Willemze, J.F. Apperley, A. Gratwohl, E.F.M. Posthuma, B. Hertenstein, G.M.T. Schreuder, R.F. Schipper, J. D’Amaro, E. Roosnek, J. Hermans, HLA-B8 and HLA-A3 Coexpressed With HLA-B8 Are Associated With a Reduced Risk of the Development of Chronic Myeloid Leukemia Blood. ,vol. 93, pp. 3863- 3865 ,(1999) , 10.1182/BLOOD.V93.11.3863
E. Donnall Thomas, Rainer Storb, Reginald A. Clift, Alexander Fefer, F. Leonard Johnson, Paul E. Neiman, Kenneth G. Lerner, Harold Glucksberg, C. Dean Buckner, Bone-Marrow Transplantation New England Journal of Medicine. ,vol. 292, pp. 895- 902 ,(1975) , 10.1056/NEJM197504242921706
M Bocchia, T Korontsvit, Q Xu, S Mackinnon, SY Yang, A Sette, DA Scheinberg, Specific human cellular immunity to bcr-abl oncogene-derived peptides Blood. ,vol. 87, pp. 3587- 3592 ,(1996) , 10.1182/BLOOD.V87.9.3587.BLOODJOURNAL8793587
E Holler, HJ Kolb, A Moller, J Kempeni, S Liesenfeld, H Pechumer, W Lehmacher, G Ruckdeschel, B Gleixner, C Riedner, Increased serum levels of tumor necrosis factor alpha precede major complications of bone marrow transplantation [see comments] Blood. ,vol. 75, pp. 1011- 1016 ,(1990) , 10.1182/BLOOD.V75.4.1011.1011
D Niederwieser, A Grassegger, J Aubock, M Herold, D Nachbaur, A Rosenmayr, A Gachter, W Nussbaumer, S Gaggl, M Ritter, Correlation of minor histocompatibility antigen-specific cytotoxic T lymphocytes with graft-versus-host disease status and analyses of tissue distribution of their target antigens Blood. ,vol. 81, pp. 2200- 2208 ,(1993) , 10.1182/BLOOD.V81.8.2200.2200
PJ Martin, G Schoch, L Fisher, V Byers, FR Appelbaum, GB McDonald, R Storb, JA Hansen, A retrospective analysis of therapy for acute graft-versus-host disease: secondary treatment Blood. ,vol. 77, pp. 1821- 1828 ,(1990) , 10.1182/BLOOD.V77.8.1821.1821